• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉和脂肪量的连续观察作为死亡供肝移植的预后因素。

Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation.

机构信息

Department of Radiology and Center for Imaging Sciences, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean J Radiol. 2021 Feb;22(2):189-197. doi: 10.3348/kjr.2019.0750. Epub 2020 Nov 3.

DOI:10.3348/kjr.2019.0750
PMID:33236536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7817639/
Abstract

OBJECTIVE

Muscle depletion in patients undergoing liver transplantation affects the recipients' prognosis and therefore cannot be overlooked. We aimed to evaluate whether changes in muscle and fat mass during the preoperative period are associated with prognosis after deceased donor liver transplantation (DDLT).

MATERIALS AND METHODS

This study included 72 patients who underwent DDLT and serial computed tomography (CT) scans. Skeletal muscle index (SMI) and fat mass index (FMI) were calculated using the muscle and fat area in CT performed 1 year prior to surgery (1 yr Pre-LT), just before surgery (Pre-LT), and after transplantation (Post-LT). Simple aspects of serial changes in muscle and fat mass were analyzed during three measurement time points. The rate of preoperative changes in body composition parameters were calculated (preoperative ΔSMI [%] = [SMI at Pre-LT - SMI at 1 yr Pre-LT] / SMI at Pre-LT × 100; preoperative ΔFMI [%] = [FMI at Pre-LT - FMI at 1 yr Pre-LT] / FMI at Pre-LT × 100) and assessed for correlation with patient survival.

RESULTS

SMI significantly decreased during the preoperative period (mean preoperative ΔSMI, -13.04%, < 0.001). In the multivariable analysis, preoperative ΔSMI ( = 0.016) and model for end-stage liver disease score ( = 0.011) were independent prognostic factors for overall survival. The mean survival time for patients with a threshold decrease in the preoperative ΔSMI (≤ -30%) was significantly shorter than for other patients ( = 0.007). Preoperative ΔFMI was not a prognostic factor but FMI increased during the postoperative period ( = 0.009) in all patients.

CONCLUSION

A large reduction in preoperative SMI was significantly associated with reduced survival after DDLT. Therefore, changes in muscle mass during the preoperative period can be considered as a prognostic factor for survival after DDLT.

摘要

目的

肝移植患者的肌肉耗竭会影响受者的预后,因此不容忽视。本研究旨在评估术前肌肉和脂肪量的变化是否与死后供肝移植(DDLT)后的预后相关。

材料和方法

本研究纳入了 72 例行 DDLT 并进行了连续 CT 扫描的患者。使用术前 1 年(1 yr Pre-LT)、术前(Pre-LT)和移植后(Post-LT)的 CT 肌肉和脂肪面积计算骨骼肌指数(SMI)和脂肪质量指数(FMI)。分析了三个测量时间点肌肉和脂肪量的连续变化的简单方面。计算了术前身体成分参数变化率(术前ΔSMI [%] = [Pre-LT 时的 SMI - 1 yr Pre-LT 时的 SMI] / Pre-LT 时的 SMI × 100;术前ΔFMI [%] = [Pre-LT 时的 FMI - 1 yr Pre-LT 时的 FMI] / Pre-LT 时的 FMI × 100),并评估其与患者生存的相关性。

结果

SMI 在术前期间显著下降(平均术前ΔSMI,-13.04%,<0.001)。在多变量分析中,术前ΔSMI( = 0.016)和终末期肝病模型评分( = 0.011)是总生存率的独立预后因素。术前ΔSMI 阈值降低(≤-30%)患者的平均生存时间明显短于其他患者( = 0.007)。术前ΔFMI 不是预后因素,但所有患者的 FMI 在术后期间增加( = 0.009)。

结论

术前 SMI 的大量减少与 DDLT 后生存时间显著缩短相关。因此,术前期间肌肉量的变化可被视为 DDLT 后生存的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/2336baefebc2/kjr-22-189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/fb2e5572c93c/kjr-22-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/e44a9bfe81b2/kjr-22-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/16949a6dd429/kjr-22-189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/2336baefebc2/kjr-22-189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/fb2e5572c93c/kjr-22-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/e44a9bfe81b2/kjr-22-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/16949a6dd429/kjr-22-189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ee/7817639/2336baefebc2/kjr-22-189-g004.jpg

相似文献

1
Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation.肌肉和脂肪量的连续观察作为死亡供肝移植的预后因素。
Korean J Radiol. 2021 Feb;22(2):189-197. doi: 10.3348/kjr.2019.0750. Epub 2020 Nov 3.
2
Perioperative Skeletal Muscle Fluctuations in High-Acuity Liver Transplantation.高 acuity 肝移植围手术期骨骼肌波动情况 (注:这里的“acuity”不太明确准确含义,推测可能是“急症、高风险等类似意思”,具体需结合原文完整语境判断)
J Surg Res. 2022 Feb;270:386-393. doi: 10.1016/j.jss.2021.09.030. Epub 2021 Nov 2.
3
Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes.腹部 CT 测量的人体成分与尸体供肝移植后移植结局的关系。
Radiology. 2023 Mar;306(3):e212403. doi: 10.1148/radiol.212403. Epub 2022 Oct 25.
4
Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.肌少症性肥胖对活体供肝移植患者结局的影响。
Clin Nutr. 2019 Oct;38(5):2202-2209. doi: 10.1016/j.clnu.2018.09.019. Epub 2018 Sep 28.
5
Chronological changes in skeletal muscle mass following living-donor liver transplantation: An analysis of the predictive factors for long-term post-transplant low muscularity.肝移植术后骨骼肌质量的时间变化:长期移植后低肌肉量的预测因素分析。
Clin Transplant. 2019 Apr;33(4):e13495. doi: 10.1111/ctr.13495. Epub 2019 Mar 3.
6
Newly developed sarcopenia after liver transplantation, determined by a fully automated 3D muscle volume estimation on abdominal CT, can predict post-transplant diabetes mellitus and poor survival outcomes.新发展的肝移植后肌肉减少症,通过腹部 CT 的全自动 3D 肌肉体积估计来确定,可以预测肝移植后糖尿病和不良生存结局。
Cancer Imaging. 2023 Aug 2;23(1):73. doi: 10.1186/s40644-023-00593-4.
7
Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.低皮下脂肪量与肝硬化女性患者的死亡率升高相关。
J Hepatol. 2018 Sep;69(3):608-616. doi: 10.1016/j.jhep.2018.04.015. Epub 2018 Apr 28.
8
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.前瞻性验证研究中,肌肉减少症对卵巢癌患者生存无影响。
Gynecol Oncol. 2020 Dec;159(3):706-711. doi: 10.1016/j.ygyno.2020.09.042. Epub 2020 Oct 2.
9
Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy.转移性肾细胞癌患者接受减瘤性肾切除术后骨骼肌质量的变化可预测生存情况
Clin Genitourin Cancer. 2017 Apr;15(2):e229-e238. doi: 10.1016/j.clgc.2016.08.004. Epub 2016 Aug 10.
10
Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.成人对成人活体肝移植队列研究中的复发性原发性硬化性胆管炎:活体供肝与尸体供肝受者的危险因素比较
Liver Transpl. 2016 Sep;22(9):1214-22. doi: 10.1002/lt.24496. Epub 2016 Aug 2.

引用本文的文献

1
Effect of sarcopenia on the survival of patients undergoing liver transplantation: a meta-analysis.肌肉减少症对肝移植患者生存的影响:一项荟萃分析。
Surg Today. 2025 Jun;55(6):803-813. doi: 10.1007/s00595-025-03008-y. Epub 2025 Feb 10.
2
Sarcopenia As a Predictor of Survival and Complications of Patients With Cirrhosis After Liver Transplantation: A Systematic Review and Meta-Analysis.肌肉减少症作为肝移植后肝硬化患者生存和并发症的预测指标:一项系统评价和荟萃分析
Clin Transplant. 2025 Feb;39(2):e70088. doi: 10.1111/ctr.70088.
3
Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer.

本文引用的文献

1
Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis.腹横肌厚度对肝硬化患者肌少症诊断的临床价值。
Clin Mol Hepatol. 2018 Sep;24(3):319-330. doi: 10.3350/cmh.2017.0077. Epub 2018 Apr 30.
2
A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.一个包含肌肉减少症的模型在预测肝硬化肝移植候选者等待名单死亡率方面优于 MELD 评分:一项全国队列的竞争风险分析。
J Hepatol. 2018 Apr;68(4):707-714. doi: 10.1016/j.jhep.2017.11.030. Epub 2017 Dec 6.
3
FOLFIRINOX方案后局部区域治疗应用时骨骼肌指数变化与胰腺癌生存情况
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e16343. doi: 10.1002/jcsm.13643. Epub 2024 Nov 23.
4
Fat Mass Index Predicts the Effect of Weight Loss and Quality of Life Early After Laparoscopic Sleeve Gastrectomy.体脂指数预测腹腔镜袖状胃切除术早期减肥效果和生活质量。
Obes Surg. 2024 Nov;34(11):4125-4135. doi: 10.1007/s11695-024-07518-5. Epub 2024 Sep 28.
5
Looking Ahead to 2022 for the .展望2022年的…… (原文不完整,翻译可能不准确,你可补充完整原文后继续向我提问)
Korean J Radiol. 2022 Jan;23(1):6-9. doi: 10.3348/kjr.2021.0844.
6
Mistakes to Avoid for Accurate and Transparent Reporting of Survival Analysis in Imaging Research.影像研究中生存分析准确且透明报告应避免的错误。
Korean J Radiol. 2021 Oct;22(10):1587-1593. doi: 10.3348/kjr.2021.0579. Epub 2021 Aug 19.
7
The adverse impact, assessment and management of sarcopenia in liver transplantation candidates and recipients.肝移植候选者和受者中肌肉减少症的不良影响、评估及管理
Hepatobiliary Surg Nutr. 2021 Aug;10(4):575-578. doi: 10.21037/hbsn-21-145.
8
Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure.骨骼肌指数用于预测慢加急性肝衰竭患者短期死亡率。
Sci Rep. 2021 Jun 15;11(1):12593. doi: 10.1038/s41598-021-92087-1.
Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.
肝硬化患者肌肉减少症的预后价值:一项系统评价和荟萃分析。
PLoS One. 2017 Oct 24;12(10):e0186990. doi: 10.1371/journal.pone.0186990. eCollection 2017.
4
Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.磁共振成像中无脂肪肌肉质量可预测代偿性肝硬化急性失代偿期肝衰竭和生存率。
Hepatology. 2018 Mar;67(3):1014-1026. doi: 10.1002/hep.29602. Epub 2018 Jan 24.
5
Sarcopenia in liver transplant recipients: its relevance to peritransplant morbidity and mortality.肝移植受者的肌肉减少症:其与移植围手术期发病率和死亡率的相关性。
Hepatobiliary Surg Nutr. 2017 Jun;6(3):196-199. doi: 10.21037/hbsn.2017.03.10.
6
Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.活体肝移植前肌肉减少症的影响及肌肉减少症参数在移植后的变化
Nutrition. 2017 Jan;33:195-198. doi: 10.1016/j.nut.2016.07.002. Epub 2016 Jul 27.
7
Sarcopenia from mechanism to diagnosis and treatment in liver disease.肝脏疾病中肌肉减少症:从机制到诊断与治疗
J Hepatol. 2016 Dec;65(6):1232-1244. doi: 10.1016/j.jhep.2016.07.040. Epub 2016 Aug 8.
8
Systematic Review and Meta-Analysis of the Impact of Computed Tomography-Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.计算机断层扫描评估的骨骼肌质量对等待或接受肝移植患者预后影响的系统评价和荟萃分析
Am J Transplant. 2016 Aug;16(8):2277-92. doi: 10.1111/ajt.13732. Epub 2016 Apr 4.
9
Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation.新发肌肉减少症作为肝移植患者生存的预后因素
PLoS One. 2015 Nov 30;10(11):e0143966. doi: 10.1371/journal.pone.0143966. eCollection 2015.
10
Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.胃肠道和肝胆恶性肿瘤患者的肌肉减少症的系统评价。
Br J Surg. 2015 Nov;102(12):1448-58. doi: 10.1002/bjs.9893. Epub 2015 Sep 16.